Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways

Behavioural Brain Research

Volumn 204, Issue 1, 2009, Pages 235-240

  Iwai, Takashi ^a   Hayashi, Yohei ^a   Narita, Saori ^a   Kasuya, Yuko ^a   Jin, Kazushi ^a   Tsugane, Mamiko ^a   Oka, Jun Ichiro ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Antidepressant; Dopamine; Forced swim test; Glucagon like peptide 2; Major depression; Noradrenaline; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ALPHA 1 ADRENERGIC RECEPTOR; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; FENCLONINE; GLUCAGON LIKE PEPTIDE 2; METERGOLINE; MONOAMINE; PRAZOSIN; RACLOPRIDE; SEROTONIN 1A RECEPTOR; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MENTAL TEST; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCAGON-LIKE PEPTIDE 2; MALE; MEMORY; MICE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; SWIMMING;

EID: 67849101000     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.06.020     Document Type: Article

References (50)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (2000), American Psychiatric Association, Washington, DC pp. 356-7 [text version (DSM-IV-TR)]
2. Bai F., Li X., Clay M., Lindstrom T., and Skolnick P. Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 70 (2001) 187-192
3. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res Brain Res Rev 28 (1998) 309-369
4. Blier P., Bergeron R., and de Montigny C. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology 16 (1997) 333-338
5. Blier P., and Ward N.M. Is there a role for 5-HT1A agonists in the treatment of depression?. Biol Psychiatry 53 (2003) 193-203
6. Borsini F., Lecci A., Sessarego A., Frassine R., and Meli A. Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation. Psychopharmacology (Berl) 97 (1989) 183-188
7. Bourin M. Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?. Fundam Clin Pharmacol 4 (1990) 49-64
8. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry 157 (2000) 115-118
9. Chaput Y., de Montigny C., and Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5 (1991) 219-229
10. Cryan J.F., and Leonard B.E. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Hum Psychopharmacol 15 (2000) 113-135
11. Cryan J.F., and Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9 (2004) 326-357
12. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29 (2005) 571-625
13. Danysz W., Kostowski W., Kozak W., and Hauptmann M. On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression. Pol J Pharmacol Pharm 38 (1986) 285-298
14. Davy M., Midol Monnet M., Heimburger M., Wepierre J., and Cohen Y. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats. J Pharmacol 17 (1986) 28-36
15. De Pablo J.M., Parra A., Segovia S., and Guillamon A. Learned immobility explains the behavior of rats in the forced swimming test. Physiol Behav 46 (1989) 229-237
16. De Pablo J.M., Ortiz-Caro J., Sanchez-Santed F., and Guillamon A. Effects of diazepam, pentobarbital, scopolamine and the timing of saline injection on learned immobility in rats. Physiol Behav 50 (1991) 895-899
17. Dekeyne A., and Millan M.J. Discriminative stimulus properties of antidepressant agents: a review. Behav Pharmacol 14 (2003) 391-407
18. Dhanvantari S., Seidah N.G., and Brubaker P.L. Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol 10 (1996) 342-355
19. Drucker D.J., Erlich P., Asa S.L., and Brubaker P.L. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93 (1996) 7911-7916
20. Duterte-Boucher D., Leclere J.F., Panissaud C., and Costentin J. Acute effects of direct dopamine agonists in the mouse behavioral despair test. Eur J Pharmacol 154 (1988) 185-190
21. Estall J.L., and Drucker D.J. Tales beyond the crypt: glucagon-like peptide-2 and cytoprotection in the intestinal mucosa. Endocrinology 146 (2005) 19-21
22. Frazer A. Norepinephrine involvement in antidepressant action. J Clin Psychiatry 61 10 (Suppl.) (2000) 25-30
23. Goodwin F.K., and Bunney Jr. W.E. Depressions following reserpine: a reevaluation. Semin Psychiatry 3 (1971) 435-448
24. Haddjeri N., Blier P., and de Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci 18 (1998) 10150-10156
25. Haley T.J., and Mccormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12 (1957) 12-15
26. Jackson D.M., and Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64 (1994) 291-370
27. Jeppesen P.B., Hartmann B., Thulesen J., Graff J., Lohmann J., Hansen B.S., et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120 (2001) 806-815
28. Kitada Y., Miyauchi T., Kanazawa Y., Nakamichi H., and Satoh S. Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test. Neuropharmacology 22 (1983) 1055-1060
29. Lovshin J., Estall J., Yusta B., Brown T.J., and Drucker D.J. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem 276 (2001) 21489-21499
30. Lovshin J.A., Huang Q., Seaberg R., Brubaker P.L., and Drucker D.J. Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells. Endocrinology 145 (2004) 3495-3506
31. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
32. Masuda Y., Ohnuma S., and Sugiyama T. Alpha 2-adrenoceptor activity induces the antidepressant-like glycolipid in mouse forced swimming. Methods Find Exp Clin Pharmacol 23 (2001) 19-21
33. Millan M.J. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur J Pharmacol 500 (2004) 371-384
34. Mojsov S., Heinrich G., Wilson I.B., Ravazzola M., Orci L., and Habener J.F. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 261 (1986) 11880-11889
35. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., and Cryan J.F. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 29 (2004) 1050-1062
36. Naranjo C.A., Tremblay L.K., and Busto U.E. The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 25 (2001) 781-823
37. Nelson D.W., Sharp J.W., Brownfield M.S., Raybould H.E., and Ney D.M. Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat. Endocrinology 148 (2007) 1954-1962
38. Nutt D.J. The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry 67 6 (Suppl.) (2006) 3-8
39. O'Leary O.F., Bechtholt A.J., Crowley J.J., Hill T.E., Page M.E., and Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) 192 (2007) 357-371
40. Page M.E., Detke M.J., Dalvi A., Kirby L.G., and Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 147 (1999) 162-167
41. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
42. Porsolt R.D. Animal model of depression. Biomedicine 30 (1979) 139-140
43. Redrobe J.P., Bourin M., Colombel M.C., and Baker G.B. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) 138 (1998) 1-8
44. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
45. Sugimoto Y., Kajiwara Y., Hirano K., Yamada S., Tagawa N., Kobayashi Y., et al. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Eur J Pharmacol 592 (2008) 116-122
46. Tang Christensen M., Larsen P.J., Thulesen J., Romer J., and Vrang N. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 6 (2000) 802-807
47. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20 (2000) 4030-4036
48. Velazquez E., Ruiz Albusac J.M., and Blazquez E. Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes. Eur J Biochem 270 (2003) 3001-3009
49. Welner S.A., De Montigny C., Desroches J., Desjardins P., and Suranyi-Cadotte B.E. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse 4 (1989) 347-352
50. Willner P. Dopamine and depression: a review of recent evidence. II. Theoretical approaches. Brain Res 287 (1983) 225-236